Immunogen (IMGN) Misses Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
UPDATE: H.C. Wainwright Upgrades Immunogen Inc. (IMGN) to Buy
May 6, 2019 7:06 AM EDT(Updated - May 6, 2019 7:45 AM EDT)
(updated to add analyst comment)
H.C. Wainwright analyst Debjit Chattopadhyay upgraded Immunogen Inc. (NASDAQ: IMGN) from Neutral to Buy with a price target of $7.00 (from $3.50).
The analyst comments "From current levels, we... More



